Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +41.70%
#2 0G 0G +28.35%
#3 Fake World Assets Fake World Assets +21.19%
#4 Nockchain Nockchain +19.03%
#5 Full Moon Full Moon +17.70%
#6 Zora Zora +17.60%
#7 SAFEcoin SAFEcoin +17.38%
#8 Notcoin Notcoin +16.69%
#9 Axelar Axelar +15.62%
#10 ADO Protocol ADO Protocol +15.45%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

KYTX
Rang in Aktien #13175
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Aktienkurs
$8.46
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$514.33M
Veränderung (1 Tag)
-2.08%
Veränderung (1 Jahr)
128.03%
Land
US
Handel Kyverna Therapeutics, Inc. (KYTX)

Kategorie

Healthcare
EPS für Kyverna Therapeutics, Inc. (KYTX)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Kyverna Therapeutics, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Kyverna Therapeutics, Inc. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH